Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) of the enolic acid class, primarily inhibits cyclooxygenase-2 (COX-2) and is used to manage inflammatory conditions such as osteoarthritis and rheumatoid arthritis7. This evidence concerns the gene PTGS2 and osteoarthritis.